Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Mediated Thrombocytopenia”

414 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 414 results

Not applicableNot Yet RecruitingNCT06137105
What this trial is testing

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

Who this might be right for
ITP - Immune Thrombocytopenia
Assiut University 100
Early research (Phase 1)Looking for participantsNCT06534021
What this trial is testing

IASO-782 in Autoimmune Hematological Diseases

Who this might be right for
Autoimmune ThrombocytopeniaWarm Autoimmune Haemolytic Anaemia
Shanghai IASO Biotechnology Co., Ltd 16
Not applicableStudy completedNCT05613296
What this trial is testing

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

Who this might be right for
ITP - Immune ThrombocytopeniaChronic ITPRefractory ITP
Gruppo Italiano Malattie EMatologiche dell'Adulto 95
Not applicableStudy completedNCT00005570
What this trial is testing

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicImmune Thrombocytopenic Purpura
National Heart, Lung, and Blood Institute (NHLBI) 200
Early research (Phase 1)UnknownNCT04741139
What this trial is testing

Post IVIG Medication in Children With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 20
Testing effectiveness (Phase 2)Looking for participantsNCT07362199
What this trial is testing

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Looking for participantsNCT07657793
What this trial is testing

Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia

Who this might be right for
Systemic Lupus ErythematosusImmune Thrombocytopenia
Chinese SLE Treatment And Research Group 164
Not applicableNot Yet RecruitingNCT06790888
What this trial is testing

Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure

Who this might be right for
ITP - Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 78
Large-scale testing (Phase 3)Study completedNCT02391272
What this trial is testing

Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Shandong University 31
Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Large-scale testing (Phase 3)Study completedNCT06288932
What this trial is testing

Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.

Who this might be right for
Immune Thrombocytopenia Purpura
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 118
Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04812925
What this trial is testing

Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 173
Testing effectiveness (Phase 2)UnknownNCT02757196
What this trial is testing

Treatment of ITP With Rituximab and / or Accutane

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 112
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Testing effectiveness (Phase 2)WithdrawnNCT06176235
What this trial is testing

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital
Testing effectiveness (Phase 2)Active Not RecruitingNCT06199089
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 45
Early research (Phase 1)Not Yet RecruitingNCT07599280
What this trial is testing

Universal STAR-T Cell Injection in R/R Autoimmune Diseases.

Who this might be right for
Immune Thrombocytopenia
Jian Zhu 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603557
What this trial is testing

Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

Who this might be right for
Chronic Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 52
Testing effectiveness (Phase 2)WithdrawnNCT01440361
What this trial is testing

Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline
Next Page